Breaking News
January 17, 2018 - Raw Meat Not the Safest Choice for Your Dog or for You
January 17, 2018 - High-Dose Aspirin Preferred for Kawasaki’s
January 17, 2018 - Study suggests risk management approach to combat EMS fatigue
January 17, 2018 - A new therapy against obesity
January 17, 2018 - Doctors warn against holding your nose and closing your mouth to contain a sneeze
January 17, 2018 - Measles outbreak alarms public health officials
January 17, 2018 - FDA Slaps Class Warning on Gadolinium Contrast Agents
January 17, 2018 - Distinct human mutations can alter the effect of medicine
January 17, 2018 - ASIT biotech’s new article presents clinical results of gp
January 17, 2018 - Alternative tobacco use by adolescents associated with greater odds of future cigarette smoking
January 17, 2018 - A High-Salt Diet Produces Dementia In Mice
January 17, 2018 - Scientists provide insights into crucial interaction for DNA repair
January 17, 2018 - Sanofi and Regeneron Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
January 17, 2018 - Morning Break: Pfizer Kills AD/PD Pipeline; Trump Affirms His Mental Health; Humira Pricing Strategy
January 17, 2018 - Researchers see gene influencing performance of sleep-deprived people
January 17, 2018 - Fast food triggers the immune system making it hyperactive
January 17, 2018 - Scientists find increased risk of HIV outbreaks in Ukraine due to war-related migration
January 17, 2018 - New universal flu vaccine moves to clinical trial phase and could be a reality soon
January 17, 2018 - Cocaine de-addiction breakthrough shows promise
January 17, 2018 - FDA Accepts New Drug Application for Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
January 17, 2018 - Robotic Telestenting; BP Cuff Smartwatch; Medicare Bundled Care
January 17, 2018 - New cellular approach found to control progression of chronic kidney disease
January 17, 2018 - Lamprey genes provide clues to repair spinal cord damage, finds study
January 17, 2018 - Tissue-based soft robot could lead to advances in bio-inspired robotics
January 17, 2018 - Mostly the healthy and wealthy Americans use mobile phone apps to track sleep habits
January 17, 2018 - FDA Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter
January 16, 2018 - NeuroBreak: Rough Days for Neuroscience Research; Another Migraine Drug Advances
January 16, 2018 - The ‘greatest pandemic in history’ was 100 years ago – but many of us still get the basic facts wrong
January 16, 2018 - Serena Williams Shares Childbirth Ordeal
January 16, 2018 - The Artificial Brain as Doctor
January 16, 2018 - Type 2 diabetes has hepatic origins
January 16, 2018 - Expert discusses how to identify, support individuals with drug or alcohol addiction in workplace
January 16, 2018 - Starting menstruation early increases risk of cardiovascular disease and stroke in later life
January 16, 2018 - CapsoVision receives CE Mark approval for use of CapsoCam Plus System in pediatric patients
January 16, 2018 - Researchers develop new dynamic statistical model to follow gene expressions over time
January 16, 2018 - Alzheimer’s ‘looks like me, it looks like you’
January 16, 2018 - By the Numbers: Physicians’ Economic Impact
January 16, 2018 - Sound Health | NIH News in Health
January 16, 2018 - Modifying baby formula doesn’t prevent type 1 diabetes in children
January 16, 2018 - Energy drinks dangerous for kids
January 16, 2018 - When you need a breast screening, should you get a 3-D mammogram?
January 16, 2018 - Johns Hopkins gets approval to perform HIV positive to HIV positive living donor kidney transplants
January 16, 2018 - The Salk Institute and Indivumed collaborate for cutting-edge cancer research
January 16, 2018 - Study reveals negative long-term effects of heavy cannabis use on brain function and behavior
January 16, 2018 - Many gym-goers injure themselves by pushing harder to be better than friends
January 16, 2018 - Risankizumab Meets All Primary Endpoints Reporting Positive Results in Fourth Pivotal Phase 3 Psoriasis Study
January 16, 2018 - Federal Junk Food Tax Feasible, Study Says
January 16, 2018 - Do girls have stronger teeth than boys?
January 16, 2018 - New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack
January 16, 2018 - How fatal mitochondrial diseases may strike offspring of families with no history of the conditions
January 16, 2018 - TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR
January 16, 2018 - Morning Break: Food Pharmacies; Obamacare Sign-ups Dip; Top Pot Studies
January 16, 2018 - Blood pressure declines 14 to 18 years before death
January 16, 2018 - ViLim Ball technology helps reduce uncontrollable shaking hands
January 16, 2018 - Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies
January 16, 2018 - In Wisconsin, hopes rise for production of a lifesaving radioactive isotope
January 16, 2018 - Researchers develop software to better predict risk of leakage around aortic stents
January 16, 2018 - Bile acids could directly burn away lipids in the fat depots
January 16, 2018 - Cycling does not negatively impact sexual and urinary health finds study
January 16, 2018 - Severe peer victimization in childhood may contribute to mental health issues in adolescence
January 16, 2018 - Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma
January 16, 2018 - Just How Often Do Patients Turn Post-Surgical Opioids Into a Habit?
January 16, 2018 - Opioid addiction – Genetics Home Reference
January 16, 2018 - Incomplete revascularization in PCI linked to higher mortality
January 16, 2018 - Machine learning algorithm uses brain scans to predict language ability in deaf children
January 16, 2018 - Penn scientists identify new therapeutic target for treatment of melanoma
January 16, 2018 - The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health
January 16, 2018 - Early influenza testing is critical to prevent serious complications
January 16, 2018 - Study Gets to the Core of Back Pain in Runners
January 16, 2018 - Year in Review: Ophthalmology | Medpage Today
January 16, 2018 - ClinicalTrials.gov: Marijuana Use
January 16, 2018 - Researchers create novel compound targeting melanoma cells
January 16, 2018 - FDA grants approval for first drug to treat inherited breast cancer
January 16, 2018 - Researchers develop remote-controlled mechanogenetics system to target and kill cancer cells
January 16, 2018 - Fresh, Frozen Embryos Equal in IVF
January 16, 2018 - Research shows biological clocks could improve brain cancer treatment
January 16, 2018 - Dire view from within accident and emergency wards of England and Wales
January 16, 2018 - Study reveals how devastating mitochondrial diseases strike families without any previous history
January 16, 2018 - Experts look for ways to standardize treatments for pediatric rheumatic diseases
January 16, 2018 - Teens who watch TV shows with ads likely to eat more junk food
A Patient’s Journey: And Now, a Word from a Pathologist

A Patient’s Journey: And Now, a Word from a Pathologist

image_pdfDownload PDFimage_print

I recently ran across a wide-ranging blog, “Getting More From Les,” written by suburban Chicago pathologist Lester Raff, MD.

I was amused by his tongue-in-cheek take on pathologists like him “giving (prostate) cancer” to patients. Actually, giving them prostate cancer diagnoses.

I wrote a fan note to Raff and told him there was another prostate cancer blogger in town. We started an email exchange, which I will share shortly.

We look at the pathology slide from different vantage points. Me with a Gleason 6 diagnosed by a pathologist like him. He as the expert using the art and science of pathology to diagnose cancer as lab director for UroPartners, a large urology group in the Chicago area. (He stresses in his blog and in his conversation with me that he is expressing his own opinions, not those of UroPartners.)

It turns out we had more in common. When he graduated from eighth grade, he had his eye on journalism. He wanted to attend the highly regarded Medill School of Journalism where, as it happens, I have taught in the grad school over the past 10 years.

But he took a radical turn and became a pathologist. Medicine’s gain has been journalism’s loss, though Les keeps a hand in journalism through his blog.

I had some questions from the patient point of view and solicited others from patient advocates Mike Scott, founder of Prostate Cancer International and Rick Davis, founder of Answer Cancer Foundation.

Here is my Q & A with Raff.

Wolinsky: “Do you often speak with men to whom you ‘give’ prostate cancer.”

Raff: “It is very interesting to me to see your perspective. As a pathologist I rarely talk with patients, other than friends and relatives whose biopsies I often wind up reading. I would enjoy talking with more patients, but only a few ever give me a call, even though my name and phone number are on our reports.

When I speak with patients, I try to restrict myself to the diagnosis of the prostate cancer and to the prognostic markers that can be obtained from the biopsy specimen.

I do not claim to be an expert on the varying, and expanding, armamentarium of treatments now available.”

Wolinsky: “It is my experience that many physicians refuse to have PSA screening because they see little value in it. What do you think about the value of PSAs?”

Raff: “I do believe in PSA screening and the use of prostate biopsies. On a personal level, I lost my dad to prostate cancer, and on a professional level I have seen a real (though anecdotal — I don’t have a full data analysis) increase in high-grade prostate cancer since the decline of PSA testing. I realize PSA testing grabs a lot of men (such as you) in its net that may not need therapy, but it also finds the men who have potentially aggressive disease and will benefit from earlier therapy.”

Wolinsky: “In the same vein, many men in active surveillance programs are rebelling against biopsies because they think they can rely on multi-parameter MRIs. (My urologist, Brian Helfand, MD, PhD, is not one. He sees biopsies as essential for active surveillance, the ‘gold standard.’). What do you think?”

Raff: “My experience with MRI at this time is that it is sub-optimal, with many false positives. I cannot speak to the false negative rate — if the men don’t get biopsied, I have no way of knowing whether or not disease is present.”

Wolinsky: “We know that different pathologists may grade slides differently … but what do you do to optimize the chances that you are ‘right’ as often as possible? For example, if you have a sense of difficulty in deciding whether a particular patient has Gleason 3 + 4 or 4 + 3, can you and do you have a colleague take a look at that particular set of slides too, to get a second ‘in-house’ opinion before a report is written up? Should that be noted in the pathology report when it happens?”

Raff: “In my institution, ALL malignant cases are reviewed at a daily quality assurance committee review at a video microscope. We frequently discuss the appropriate grade on a particular slide. All our reports document that a QA review occurred. I also track the opinions of other labs when our slides are sent to other institutions for second opinion, to see if we have any institutional bias toward up or down grading.”

Wolinsky: “Have there been technological improvements in the way prostate cancer pathology is carried out that have improved the ability to ‘see’ critical histopathological information?”

Raff: “There have not been significant changes in diagnostic techniques. There have been changes in patient safety in regards to proper identification of biopsies. We initiated and published an inking technique, and DNA patient identity testing (Know Error) has been embraced by many labs.

The other significant change is in the use of molecular diagnostics for prognostic markers in prostate cancer, as well as to try to identify patients with negative biopsies who may still be at significant risk for prostate cancer.”

Wolinsky: “What do you think about the change in the ways that the pathological findings should be reported: from Gleason patterns and Gleason scores to the new ISUP (International Society of Urological Pathology) scoring system?”

Raff: “These are cosmetic changes. All are still based on pattern recognition by the diagnosing pathologist, who in turn is dependent on receiving slides from properly obtained, processed, sectioned, and stained tissue.”

Wolinsky: “Considering just prostate specimens, what would you say are the most challenging aspects of your work?”

Raff: “It takes skill to translate a two-dimensional appearance to a three-dimensional structure, ignore distractions on the slide and in the laboratory, and to recognize mimics of cancer as well as very bland appearing malignancy.”

Wolinsky: “Why is there significant variation in how different laboratories report pathological data from biopsies? Shouldn’t there be a single standard format for reporting the key data?”

Raff: “Synoptic reporting, which meets your requirements, is required for most malignant specimens. However, it is NOT mandated for prostate biopsies, leaving each lab with freedom to include those elements they see fit, with some resultant anarchy. I believe this will change over the next few years.”

2018-03-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles